Home › Macular Degeneration › New York › Queens
Macular Degeneration clinical trials in Queens, NY
3 studies for Macular Degeneration are looking for participants at sites in and around Queens (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
RecruitingPhase 2
- Ophthalmic Consultants of Long Island, Oceanside · 11 mi away
- Long Island Vitreoretinal Consultants, Westbury · 14 mi away
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
RecruitingPhase 3
- Vitreoretinal Consultants of NY, Westbury · 14 mi away
Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneration
RecruitingObservational studyHealthy volunteers welcome
- iHealthScreen Inc., Richmond Hill · 1 mi away
About Macular Degeneration
Macular degeneration, or age-related macular degeneration (AMD), causes vision loss in older adults. Learn about the types and what can help.
More about Macular Degeneration on MedlinePlus
Macular Degeneration trials in other cities
- Dallas, TX13 studies
- Erie, PA10 studies
- The Woodlands, TX9 studies
- Sacramento, CA8 studies
- Hagerstown, MD8 studies
- Reno, NV8 studies
- Phoenix, AZ7 studies
- Cleveland, OH7 studies
- Houston, TX7 studies
- Salt Lake City, UT7 studies
- Boston, MA7 studies
- Austin, TX7 studies
Other studies in Queens
- Breast Cancer63 studies
- Non-Small Cell Lung Cancer49 studies
- Colorectal Cancer31 studies
- Metastatic Cancer28 studies
- Ovarian Cancer28 studies
- Prostate Cancer27 studies
- Cancer (all types)26 studies
- Endometrial Cancer25 studies
- Lung Cancer22 studies
- Acute Myeloid Leukemia21 studies
- Head and Neck Squamous Cell Carcinoma20 studies
- Multiple Myeloma20 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.